RESUMEN
Objectives To clarify the transition process of Brazilian mothers of children with developmental disorders residing in Japan from “mothers raising healthy children” to “mothers raising children with developmental disorders within the Japanese healthcare and welfare system.”Methods We conducted semi-structured interviews of 11 Brazilian mothers who raised their children for at least 1 year after the children were diagnosed having developmental disabilities.According to an interview guide we prepared, the mothers were requested to talk regarding raising their children and treatment and education after they suspected that their children had developmental disabilities and regarding the changes in their views about the same. The interviews were analyzed using a modified Grounded Theory Approach (M-GTA).Results and discussions The average age of the research participants was 37.4 years. The children’s age ranged between 2 to 8 years. All the children had an autism spectrum disorder. Mothers began «suspecting» that their children exhibited developmental problems around the age of 1.5 years. Some mothers experienced a sense of «diving into turmoil» when diagnosis of autism was given. Since before the diagnosis, mothers experienced a persistent and «ongoing emotional pain due to their children’s disorder». Meeting people they can trust «provided them with the support to become stronger», and were ready to do anything for their children; in other words, they became akin to [superwomen for their children]. This process was similar to that observed in a previous study involving Japanese mothers. A short time between the initial suspicion of their children’s development and the first clinical examination and taking actions toward a diagnosis, in other words, “impatience,” were characteristics of Brazilians mothers.Conclusions The transition process of Brazilians mothers was similar to that of Japanese mothers, with some distinct characteristics. Managing impatience, providing intervention after a diagnosis, and seeking support from others will promote this transition.
RESUMEN
Objective: To detect the influence of peiminine on the invasion and migration of human lung cancer A549 cells. Methods A549 cells were treated with peiminine at the final concentrations of 0, 50, 100, and 200 μmol/L, respectively. The influence of peiminine on the invasion and migration of A549 cells and its underlying mechanisms were investigated by cell invasion experiment, cell scratch experiment, real-time quantitative PCR, ELISA, and Western blotting. Results Compared with 0 μmol/L peiminine group, the cell transmembrane number and scratch wound healing rate and expressions of MMP-9 and MMP-2 in the group treated with different concentrations of peiminine significantly decreased (P < 0.01). Compared with 0 μmol/L peiminine group, the mRNA expression of E-cadherin increased significantly (P < 0.01), while the mRNA expressions of N-cadherin and vimentin decreased significantly (P < 0.01). Compared with 0 μmol/L peiminine group, FN protein expression was significantly decreased in all the groups with different concentrations of peiminine group except treatment with 50 μmol/L peiminine after 24 h (P < 0.05, 0.01). Compared with 0 μmol/L peiminine group, the ratio of p-PI3K/PI3K and p-mTOR/mTOR in all concentrations of peiminine groups and p-Akt/Akt in 100 and 200 peiminine groups were significantly decreased (P < 0.05, 0.01). Conclusion Peiminine can inhibit the invasion and migration of A549 cells, which may be related to the activation of PI3K/Akt/mTOR pathway and decreasing the epithelial- mesenchymal transition process.
RESUMEN
OBJECTIVE: To explore the effect of phase transition process of compound L-carnitine plastics on the characters of transdermal absorption, provide a theoretical evidence for the penetration enhancing effect produced from phase transition process. METHODS: The accumulated transdermal percentage of capsaicin and L-carnitine were used as measurement indicators, the experiment was finished by improved Franz diffuser and disembodied rabbit skin, the content of different components in transdermal receiving solution and in skin that received in different time was determined by HPLC, the curve of transdermal was drawn been drawn, the rule and the characters of transdermal were analyzed. RESULTS: The transdermal dynamics curve before and after the phase transition of compound L-carnitine plastics is a kind of continuous function, while it become a kind of non-continuous function during the process of the phase transition. The 95% confidence interval of the parameters of transdermal velocity and amount between sample A with transdermal enhancer and sample B without transdermal enhancer shows overlap, the difference shows no statistical significance between sample A and B. It was showed that the sample A have the same transdermal rate and amount as B. While 95% confidence interval of the parameters of transdermal velocity and amount among sample A,B and C (without film-former materials) shows no overlap, the difference shows statistical significance among sample A,B and C. When the capsaicin was used as indicators, the transdermal rate of sample A and B respectively are 1.459 times and 1.450 times of C, the transdermal amount of sample A and B respectively are 2.53 times and 1.907 times of C. When the capsaicin was used as indicators, the transdermal rate of sample A and B respectively are 1.153 times and 1.169 times of C, the transdermal amount of sample A and B respectively are 1.722 times and 1.692 times of C. CONCLUSION: Phase transition process can significantly increase both transdermal rate and transdermal amount of compound L-carnitine plastics, the time increased by phase transition process correspond to film-former time of plastics, the penetration enhancing effect produced from phase transition process is far greater than the penetration enhancing effect produced from transdermal absorption penetration enhancers(P0.05).